Pfizer's new corona vaccine "preventive effect over 90%" announced November 9, 23:31
Pfizer, a major American pharmaceutical company, has announced provisional results regarding a clinical trial of a new coronavirus vaccine under development, saying that it has a protective effect of more than 90%.
The vaccine being developed by the American pharmaceutical giant Pfizer with the German company Biontech is undergoing final clinical trials in the United States and other countries.
On the 9th, Pfizer released preliminary results of an independent external committee analyzing clinical trial data.
According to the report, out of 43,538 people in clinical trials, 94 cases were confirmed to be infected with the new coronavirus.
And, as a result of comparing and analyzing those who actually received the vaccine and those who did not, the preventive effect is estimated to exceed 90%.
It also means that the vaccinated person had no serious health effects.
Pfizer says trials are still underway and preventative efficacy figures may change in the future, but after the third week of November, when safety data are available, FDA = US Food and Drug Administration for emergency use I am applying for permission.
Regarding the outlook for vaccine supply Pfizer says it will be able to produce 50 million doses by the end of the year and up to 1.3 billion doses next year, and the Japanese government has basically agreed to receive supply for 60 million people by the end of June next year. ..